Takeda
Filings signal: Despite Covid losses, pharma earnings are promising
Each week, Pharmaceutical Technology’s journalists pick out insights from company filings that highlight sentiments in our sector. These filings signals…
Takeda closes TiGenix acquisition for about $608m
Takeda Pharmaceutical has completed its purchase of all outstanding ordinary shares of Belgium-based TiGenix for approximately $608.84m (€520m), representing €1.78…
